Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and detect breast cancer. The software analyzes a mammogram and processes the imaging data to recognize radiologic features of breast cancer and categorizes it for Breast Imaging-Reporting and Data System (BIRADS) Scoring with a fully detailed structured report. This report is then made available to a radiologist, who corroborates/validates the AI findings and signs the official report.

Medical image management and teleradiology company NucleusHealth debuted the next milestone in the Nucleus.io cloud platform with their StatStream+ technology at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30, 2018, in Chicago. StatStream+ represents a major improvement, according to the company, over the existing StatStream technology first launched within Nucleus.io to deliver medical images from the cloud quickly.

Hologic announced that the U.S. Food and Drug Administration (FDA) has cleared the LOCalizer radiofrequency identification (RFID) marker for long-term placement. With this clearance, the marker can now be implanted more than 30 days prior to a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers.

The U.S. Food and Drug Administration (FDA) has cleared the Multix Impact, an affordably priced, floor-mounted digital radiography (DR) system from Siemens Healthineers that expands access to high-quality imaging and enhances the patient experience.

Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided procedures.